| Marie Carmel Desire, MD | |
|
145 S Worthen St, Wenatchee, WA 98801 | |
| (509) 662-6761 | |
| (509) 662-3182 |
| Full Name | Marie Carmel Desire |
|---|---|
| Gender | Female |
| Speciality | Psychiatry |
| Experience | 43 Years |
| Location | 145 S Worthen St, Wenatchee, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922058783 | NPI | - | NPPES |
| 8426215 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | MD00044463 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Central Washington Hospital | Wenatchee, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Catholic Charities Of The Diocese Of Yakima | 2163594797 | 6 |
News Archive
Genzyme, a Sanofi company, announced today that the Australian Therapeutic Goods Administration has approved Lemtrada (alemtuzumab) for the treatment of relapsing forms of multiple sclerosis for patients with active disease defined by clinical or imaging features to slow the accumulation of physical disability and reduce the frequency of clinical relapses.
AstraZeneca has announced today that SYMBICORT (budesonide/formoterol fumarate dihydrate) pressurized metered dose inhaler (pMDI) is now available in the United States for the long-term maintenance treatment of asthma in patients 12 years of age and older.
Practising sport for more than an hour day reduces the risk of contracting breast cancer, and this applies to women of any age and any weight, and also unaffected by geographical location, according to research presented to the 9th European Breast Cancer Conference (EBCC-9). Compared with the least active women, those with the highest level of physical activity reduced their risk of breast cancer by 12%, researchers say.
Ultra-long-acting insulin degludec, an investigational basal insulin being developed by Novo Nordisk, showed significant blood sugar reductions in patients with type 2 diabetes.
Exposure to high levels of alcohol in adolescence may shape adult behaviors, predisposing them to a higher risk of anxiety and alcohol abuse later in life, a new study found.
› Verified 4 days ago
| Entity Name | Catholic Charities Of The Diocese Of Yakima |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316248149 PECOS PAC ID: 2163594797 Enrollment ID: O20140326000430 |
News Archive
Genzyme, a Sanofi company, announced today that the Australian Therapeutic Goods Administration has approved Lemtrada (alemtuzumab) for the treatment of relapsing forms of multiple sclerosis for patients with active disease defined by clinical or imaging features to slow the accumulation of physical disability and reduce the frequency of clinical relapses.
AstraZeneca has announced today that SYMBICORT (budesonide/formoterol fumarate dihydrate) pressurized metered dose inhaler (pMDI) is now available in the United States for the long-term maintenance treatment of asthma in patients 12 years of age and older.
Practising sport for more than an hour day reduces the risk of contracting breast cancer, and this applies to women of any age and any weight, and also unaffected by geographical location, according to research presented to the 9th European Breast Cancer Conference (EBCC-9). Compared with the least active women, those with the highest level of physical activity reduced their risk of breast cancer by 12%, researchers say.
Ultra-long-acting insulin degludec, an investigational basal insulin being developed by Novo Nordisk, showed significant blood sugar reductions in patients with type 2 diabetes.
Exposure to high levels of alcohol in adolescence may shape adult behaviors, predisposing them to a higher risk of anxiety and alcohol abuse later in life, a new study found.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Marie Carmel Desire, MD 145 S Worthen St, Wenatchee, WA 98801-3081 Ph: (509) 662-6761 | Marie Carmel Desire, MD 145 S Worthen St, Wenatchee, WA 98801 Ph: (509) 662-6761 |
News Archive
Genzyme, a Sanofi company, announced today that the Australian Therapeutic Goods Administration has approved Lemtrada (alemtuzumab) for the treatment of relapsing forms of multiple sclerosis for patients with active disease defined by clinical or imaging features to slow the accumulation of physical disability and reduce the frequency of clinical relapses.
AstraZeneca has announced today that SYMBICORT (budesonide/formoterol fumarate dihydrate) pressurized metered dose inhaler (pMDI) is now available in the United States for the long-term maintenance treatment of asthma in patients 12 years of age and older.
Practising sport for more than an hour day reduces the risk of contracting breast cancer, and this applies to women of any age and any weight, and also unaffected by geographical location, according to research presented to the 9th European Breast Cancer Conference (EBCC-9). Compared with the least active women, those with the highest level of physical activity reduced their risk of breast cancer by 12%, researchers say.
Ultra-long-acting insulin degludec, an investigational basal insulin being developed by Novo Nordisk, showed significant blood sugar reductions in patients with type 2 diabetes.
Exposure to high levels of alcohol in adolescence may shape adult behaviors, predisposing them to a higher risk of anxiety and alcohol abuse later in life, a new study found.
› Verified 4 days ago
John W Mahler, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 820 N Chelan Ave, Wenatchee, WA 98801 Phone: 509-663-8711 | |
Dr. Albert Wertz, D.O. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 620 N Emerson Ave Ste 300, Wenatchee, WA 98801 Phone: 844-867-8444 Fax: 096-452-1945 | |
Shannon R Grosdidier, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 820 N Chelan Ave, Wenatchee, WA 98801 Phone: 509-663-8711 | |
Kelly A. Condefer, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 820 N Chelan Ave, Wenatchee, WA 98801 Phone: 509-663-8711 Fax: 509-665-5890 | |
Dr. Enrique Esnard, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 820 N Chelan Ave, Wenatchee, WA 98801 Phone: 509-663-8711 | |
Ms. Jennifer Wax, Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1201 S Miller St, Wenatchee, WA 98801 Phone: 509-663-8711 | |
Lisa S Toran, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 820 N Chelan Ave, Wenatchee, WA 98801 Phone: 509-663-8711 |